Endocrine Methods and the Pituitary-Thyroid Axes

Endocrine testing differs from most of chemistry because timing, transport proteins, and assay behavior change what a number means. Hormones are secreted in pulses on circadian schedules, circulate bound to carrier proteins whose concentration shifts with physiology, and are measured by immunoassays whose failure modes produce characteristic false results. Reading a pituitary or thyroid panel therefore requires three kinds of knowledge at once: axis physiology, collection discipline, and assay mechanics.¹

Hormone chemistry and mechanism

Hormones fall into three chemical classes: amines derived from tyrosine or tryptophan, including catecholamines, thyroid hormones, serotonin, and melatonin; peptides, proteins, and glycoproteins; and steroids. Solubility follows structure. Hydrophilic hormones such as peptides, proteins, and catecholamines usually bind G-protein-coupled surface receptors and generate cAMP or inositol-trisphosphate and Ca²⁺ second messengers. Insulin and IGF-1, and growth hormone and prolactin, instead use catalytic tyrosine-kinase and Janus-kinase signaling. Lipophilic hormones, the steroids and thyroid hormones, cross the membrane and bind intracellular or nuclear receptors that directly regulate gene transcription. Signal amplification allows hormones at picomolar concentrations to produce large effects, and receptor or post-receptor defects can cause disease despite a hormone concentration within the reference interval, as in type 2 diabetes.¹

Secretion patterns and collection timing

Most axes secrete in pulses on a circadian schedule. Growth hormone pulses every 2 to 3 hours, and LH and FSH pulse frequency itself carries information, because a low GnRH pulse frequency favors FSH. ACTH reaches its nadir from 11 pm to 3 am and peaks on waking; nocturnal TSH runs roughly double daytime levels. A single random draw can neither confirm nor exclude a pulsatile-hormone deficiency, so reference conditions name the collection time, and interpretation moves to stimulation or suppression testing when a random value cannot answer the question.

Transport and the free hormone

Water-soluble hormones in circulation face degradation and filtration. Lipophilic hormones circulate bound to carrier proteins, including albumin, corticosteroid-binding globulin, sex hormone-binding globulin, and thyroxine-binding globulin. These proteins solubilize the hormone, protect it from degradation, and provide a reservoir. Only the free fraction crosses capillaries and binds receptors; the bound fraction is stored. Changes in carrier concentration alter the total hormone level without necessarily changing the biologically active free fraction. Pregnancy raises TBG through estrogen; cirrhosis and nephrosis lower albumin. Free-hormone assays avoid this ambiguity.¹

Feedback and axis localization

In negative feedback, the downstream hormone suppresses its own upstream drivers and holds a set point; T₄ and T₃ inhibit both TRH and TSH. Positive feedback amplifies toward a defined endpoint requiring an external terminator, as in oxytocin and labor contractions, the midcycle LH surge, and the coagulation cascade. Patterns localize disease along an axis:

Suspected central hyperfunction requires axis-specific testing. Autonomous glandular secretion or ectopic hormone production by a nonendocrine tumor can also cause hyperfunction.

Assay principles and failure modes

Immunoassays are either competitive, where patient antigen competes with labeled antigen for limited antibody so signal falls as analyte rises, suiting small analytes like steroids and thyroid hormones; or sandwich and immunometric, where excess capture antibody plus a labeled second antibody produce a signal that rises with analyte, suiting peptide and glycoprotein hormones with superior sensitivity and specificity.² The immunology module owns the general format mechanics; the hormone-specific failure modes belong here.¹

Hook effect. An extremely high analyte concentration saturates capture and labeled antibodies separately in a sandwich assay, preventing sandwich formation and producing a falsely low result. This failure classically occurs in prolactin macroadenoma and hCG or tumor-marker assays. Serial dilution identifies the effect, because a hooked result runs flat while a true result climbs with dilution.

Heterophile antibodies, including human anti-mouse antibodies, and rheumatoid factor may bridge sandwich-assay antibodies, causing a falsely high result, or block competitive-assay binding, causing a falsely low result. Laboratories should investigate results discordant with the clinical picture using dilution linearity, alternate-platform comparison, or blocking reagents.

Structural nonequivalence covers cross-reactivity with isoforms, fragments, and analogs. In the usual streptavidin-biotin designs, excess biotin causes falsely low sandwich results, such as TSH and troponin, and falsely high competitive results, such as free T₄, free T₃, and cortisol, though exact behavior depends on assay design. Macroprolactin, a prolactin-IgG complex that is immunoreactive but inactive, inflates sandwich prolactin results until precipitation screening unmasks it.

Fluorescence immunoassay formats. A fluorophore label absorbs light at one wavelength, the excitation, and re-emits at a longer wavelength, the emission, because some absorbed energy is lost as heat before emission; the gap between the two peaks is the Stokes shift. The emitted beam is weak relative to the excitation source, so detectors sit at 90° to the excitation beam to isolate the weak emitted signal. Three formats build on this principle:

• Fluorescence immunoassay (FIA) measures fluorescence from a fluorophore-labeled antigen or antibody directly, in either competitive or sandwich format.
• Time-resolved fluorescence immunoassay (TRFIA) uses a lanthanide chelate label, most commonly europium with terbium and samarium also used, whose fluorescence decays over microseconds to milliseconds. Background fluorescence from plasma, plastic, and reagents decays within nanoseconds. Reading is delayed and gated after a brief excitation pulse, so the short-lived background has already decayed by measurement time, raising sensitivity by suppressing that background.
• Fluorescence polarization immunoassay (FPIA) is a homogeneous competitive format for small analytes, including steroids, thyroid hormones, and therapeutic drugs. Plane-polarized excitation is absorbed by a small fluorophore-labeled antigen; a small, fast-tumbling free label emits largely depolarized light, while label bound to the much larger antibody tumbles slowly and emits light that stays polarized. Patient antigen competes with labeled antigen for antibody, so polarization falls as patient analyte concentration rises.

Practical interferences. Endogenous fluorescence from bilirubin and certain drugs adds to specimen background and can bias results. Quenching, the nonradiative loss of excitation energy, for example to hemoglobin, and the inner filter effect, in which other specimen constituents at high concentration absorb the excitation or emission wavelength and self-limit the signal, both suppress measured fluorescence. Hemolysis and turbidity from lipemia scatter and absorb light in ways that can artifactually raise or lower the reported result.

Factors complicating interpretation. Stress alters cortisol and catecholamine concentrations, while GH and prolactin responses vary with the type, duration, and context of stress. Time of day and pulsatility make collection timing part of the reference condition. The menstrual cycle and menopause shift the gonadal panel; feeding status affects leptin, GH, and AVP; and drugs may mimic or mask endocrine disease. ACE inhibitors suppress aldosterone, exogenous glucocorticoids suppress the CRH-ACTH-cortisol axis and can mimic the laboratory pattern of adrenal insufficiency, and SSRIs can provoke SIADH-like water retention.¹

The pituitary axes

Growth hormone

Growth hormone is a peptide structurally related to prolactin and human placental lactogen. Somatotrophs, more than one-third of pituitary mass, produce it under GHRH stimulation and somatostatin inhibition, and ghrelin also stimulates release. GH both builds and breaks down: it antagonizes insulin peripherally, drives hepatic gluconeogenesis and lipolysis, and mediates growth largely through hepatic IGF-1, insulin-like growth factor 1, formerly called somatomedin C.

Because GH pulses make random measurement unreliable, age-adjusted IGF-1 screens for suspected acromegaly, and protocol-defined GH suppression after oral glucose confirms an elevated or equivocal result. A validated stimulation test using assay- and body-mass-index-specific cutoffs under the local protocol establishes GH deficiency. IGF-1 also supports monitoring recombinant GH therapy and treated acromegaly.

Prolactin

Prolactin is a direct-effector hormone with diffuse target tissue and no single end organ. Unlike other anterior pituitary hormones, it sits under tonic inhibitory dopaminergic control rather than stimulatory control; dopamine is the physiologic prolactin-inhibiting factor. Anything that lowers hypothalamic dopamine, including dopamine-D2-antagonist drugs or pituitary stalk compression, raises prolactin. Prolactinoma is the most common functioning pituitary tumor; presentation depends on age and sex, with amenorrhea, galactorrhea, and infertility in premenopausal women and mass symptoms or hypogonadism in men and postmenopausal women. A prolactin concentration above 150 ng/mL supports prolactinoma and often correlates with tumor size, with the exact cutoff assay-dependent; concentrations of 25 to 100 ng/mL carry a broader differential that includes stalk compression, dopamine antagonists, primary hypothyroidism, renal failure, PCOS, breast or genital stimulation, and pregnancy. TSH and free T₄ should be measured to evaluate hypothyroid-driven hyperprolactinemia.¹

Posterior pituitary: oxytocin and AVP

Oxytocin and arginine vasopressin are cyclic nonapeptides synthesized in the supraoptic and paraventricular hypothalamic nuclei and transported down the pituitary stalk. Oxytocin drives labor and lactation let-down through positive feedback, where contraction produces oxytocin, which strengthens contraction. AVP acts at renal V2 receptors to insert aquaporin-2, at vascular V1a receptors to cause vasoconstriction, and through endothelial V2 signaling to release von Willebrand factor and factor VIII. Hypothalamic osmoreceptors trigger it at about 284 mOsm/kg, and vascular baroreceptors override osmotic suppression once blood pressure falls 5 to 10%.

Diabetes insipidus, also termed arginine-vasopressin deficiency or resistance, causes polyuria with compensatory polydipsia. Evaluate suspected DI with paired serum and urine osmolality and a validated water-deprivation, desmopressin, or stimulated-copeptin protocol under supervision. An unsupervised therapeutic desmopressin trial must not establish the diagnosis; primary polydipsia can produce severe hyponatremia under desmopressin.¹

Hypopituitarism

Loss of anterior pituitary function may be partial or complete, panhypopituitarism. It most often results from a pituitary tumor compressing normal tissue or destroying the stalk.

The thyroid axis

Synthesis and control. Iodine trapping, organification, and coupling in thyroid follicular cells yield mostly T₄, a prohormone. Peripheral 5′-deiodination converts about 35% of circulating T₄ to active T₃, which is 3 to 8 times more potent, and about 45% to inactive reverse T₃, leaving the remainder as T₄. Only 0.04% of T₄ and 0.4% of T₃ circulate free. Thyroxine-binding globulin carries the bulk, with transthyretin and albumin sharing the rest. Binding-protein shifts, classically the pregnancy-driven rise in TBG, change total T₄ and T₃ without changing the free, biologically active fraction, so free T₄ and T₃ measurement resolves the ambiguity. The hypothalamic-pituitary-thyroid axis follows the negative-feedback pattern above. TSH assays have progressed through generations of increasing sensitivity; the current third-generation detection limit of about 0.01 mU/L is sensitive enough to detect subclinical disease, minimally abnormal TSH with a still-normal free T₄.¹

Thyroid autoantibodies:

Hypothyroidism separates by axis pattern. Low free T₄ with high TSH supports primary thyroid failure, most commonly Hashimoto’s thyroiditis, an autoimmune process with a goiter and TPO-antibody positivity in 80 to 99% of cases. Low free T₄ with low or inappropriately normal TSH supports central hypothyroidism from pituitary or hypothalamic failure. Levothyroxine replacement targets normal TSH in primary disease and mid-normal free T₄ in central disease. Because levothyroxine’s half-life is about 7 days, allow roughly five half-lives, about 35 days, after a dose change before retesting at steady state.¹

Thyrotoxicosis and hyperthyroidism result from excess hormone ingestion, leakage from inflamed follicles, or true glandular overproduction. Graves’ disease, autoimmune TSH-receptor-stimulating antibodies, is the most common cause, with thyrotoxicosis, goiter, ophthalmopathy, and dermopathy; laboratory results show high free T₄ and T₃ with low or undetectable TSH, positive TRAb or TSI, and diffusely elevated radioactive iodine uptake. Toxic adenoma and multinodular goiter produce autonomous, TSH-independent hormone production with focally hot nodules on scan. Subacute thyroiditis, in postpartum, painful de Quervain’s, and painless variants, transiently leaks stored hormone, producing a thyrotoxic phase with low RAIU before a hypothyroid repair phase and eventual, usually, recovery. Amiodarone, about 37% iodine by weight, both floods the gland with iodine, where Wolff-Chaikoff inhibition causes hypothyroidism in roughly 8% of chronic users, and blocks T₄-to-T₃ conversion, while occasionally triggering thyroiditis-driven hyperthyroidism. Nonthyroidal illness, the euthyroid sick syndrome, shows low or normal TSH with low T₃ and low free T₄ in critical illness from reduced peripheral deiodination, an adaptive pattern that warrants monitoring without hormone replacement.³

References

1. Rifai N, Chiu RWK, Young I, Burnham CAD, Wittwer CT, eds. Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier; 2023.
2. Immunology serologic format mechanics: LatticeMLS. Serologic Procedures and Test Results. Competitive and sandwich formats, biotin amplification, and the shared interference table are developed there and applied to hormones here.
3. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. doi:10.1089/thy.2016.0229